San Francisco, California
London, United Kingdom
Is your company looking for funding? Or simply interested in learning more about global non-governmental life science funding opportunities? Then join us for a chance to hear from one of the world's largest charitable funders of scientific research. Don't miss the opportunity to meet one-on-one with a representative from the Wellcome Trust.
10:30am | Registration & Networking
11:00am | Presentation & Q&A
11:45pm | Lunch & Networking
12:30pm | One-on-one Meetings
Companies must apply ahead of time and be approved for a one-on-one meeting. The application period ends on August 30th. Registration to attend the general presentation and lunch will remain open until September 12th.
The Wellcome Trust is the UK's largest provider of non-governmental funding for scientific research, with an endowment of over $22 billion (US). A representative with the Trust will be in attendance on September 13th to give an overview presentation on the organization's key areas of interest, background on their current portfolio and best practices when seeking gap funding. Following the presentation, don't miss this opportunity to introduce yourself to the firm during the networking lunch. And finally, for those companies who apply online and are approved, one-on-one meetings with a representative from Wellcome Trust will provide a forum to further discuss your company with the firm's team leader.
With funding opportunities in technologies and therapies that address an unfilled medical need or are an enabling tool in healthcare research and development, leaders from all areas of the life science industry are encouraged to apply today to meet with a representative from the Wellcome Trust!
About Wellcome Trust
The Wellcome Trust is a global charitable foundation dedicated to achieving extraordinary improvements in human and animal health. It supports the brightest minds in biomedical research and the medical humanities. The Trust’s breadth of support includes public engagement, education and the application of research to improve health. It is independent of both political and commercial interests. Since 1936, Wellcome Trust has helped bridge the gap between fundamental research and commercial application by funding applied research and development projects to a stage where they are attractive to follow-on funders such as venture capital firms, industry and public-private partnerships. They support a wide array of projects worldwide that address an unfilled medical need or are an enabling tool in healthcare research and development. In 2011, the Trust spent over $1.2 billion (US) on healthcare research.
Apply for One-on-one Meeting
Free | Apply here
Presentation & Lunch Only
$25 | General Public
$35 | General Public Onsite
Includes presentation, Q&A and lunch
Presentation & One-on-one Meeting
$50 | Selected Companies
Includes presentation, Q&A, lunch, and one-on-one meeting. Companies have to be selected for a one-on-one meeting.
All companies accepted for a one-on-one meeting will be notified of acceptance and emailed a specific link to pay the required registration fees online.
Lars Gredsted, PhD | Senior Business Analyst, Wellcome Trust
Lars joined the Trust in 2010. Previously he worked with in-licensing of early stage research projects as a research analyst at Union Life Sciences. Lars has also worked as management consultant with the Boston Consulting Group, where he worked with marketing strategies for companies in the life science and industrial biotech areas. Lars earned his PhD from the European Molecular Biology Laboratory (EMBL) in Heidelberg working with transgenic mice models. He subsequently worked as a postdoc at EMBL in Heidelberg and at the Biotech Research and Innovation Center (BRIC) in Copenhagen. In addition to his PhD, Lars holds an MPhil in Bioscience Enterprise from Cambridge University and a Master of Biochemistry from the University of Copenhagen.
When & Where
JLABS @ LabCentral
JLABS, part of Johnson & Johnson Innovation, LLC, is a network of life science incubators providing emerging companies many of the advantages of being in a big company, without the capital investment. JLABS offers singular bench tops, modular wet lab units and office space on a short-term basis, allowing companies to pay only for the space they need, with an option to quickly expand when they have the resources to do so. Companies residing at JLABS also have access to core research labs hosting specialized capital equipment and shared administrative areas. JLABS is an open innovation model, and the agreement for space does not grant JLABS or Johnson & Johnson Innovation any stake or rights in the companies, nor will the companies have a guaranteed future affiliation with JLABS. The flagship facility is located in San Diego at Janssen's West Coast Research Center, and JLABS has now two established locations in San Francisco - one through a collaboration with the California Institute for Quantitative Biosciences (QB3) and a second standalone facility - one in Boston through a collaboration with Lab Central, one in Houston through a collaboration with TMC, and one in Toronto through a collaboration with MaRS. For more information please visit jlabs.jnjinnovation.com.